• Black Facebook Icon

Our Partners

The International Society for Infectious Diseases

The International Society for Infectious Diseases (ISID), established in 1986, is a non-profit organization that works to control infectious disease outbreaks and improve the care of patients afflicted with these conditions. The Society recognizes the evolving nature of infectious diseases and their ability to cross regional and national boundaries. Through training and educational opportunities for healthcare professionals, the Society works to overcome these obstacles to improve health on a global scale. ISID seeks to establish lasting partnerships with all manner of health-related disciplines to develop innovative methods for infectious disease control. 

Center for Public Health

The Medical University of Vienna (MUW) is Austria’s leading Medical University and centre of main scientific activities in the broader context of health in humans. The Center for Public Health at MUW hosts six Departments and is the home of several international public health experts with vast experience in relevant disciplines, including global health, epidemiology, health economics, social and behavioral health, family medicine, environmental health, and disease prevention research. The mission of the Center for Public Health is to advance health by improving population health and preventing disease in Austria and around the globe and to train the next generation of public health leaders. We believe in social justice, equity, and basic human rights, and are committed to promoting diversity.

ProMED-mail

Program for Monitoring Emerging Diseases (ProMED-mail) is among the largest publicly available emerging diseases and outbreak reporting systems in the world. The central purpose of ProMED is to promote communication amongst the international infectious disease community, including scientists, physicians, veterinarians, epidemiologists, public health professionals, and others interested in infectious diseases on a global scale. Originally founded in 1994, ProMED has pioneered the concept of electronic, Internet-based emerging disease and outbreak detection reporting.cAs of 2016, ProMED has more than 75,000 subscribers in over 185 countries. With an average of 13 posts per day, ProMED provides users with up-to-date information concerning infectious disease outbreaks on a global scale. ProMED is a program of the International Society for Infectious Diseases.

Center for Public Health

The Medical University of Vienna (MUW) is Austria’s leading Medical University and centre of main scientific activities in the broader context of health in humans. The Center for Public Health at MUW hosts six Departments and is the home of several international public health experts with vast experience in relevant disciplines, including global health, epidemiology, health economics, social and behavioral health, family medicine, environmental health, and disease prevention research. The mission of the Center for Public Health is to advance health by improving population health and preventing disease in Austria and around the globe and to train the next generation of public health leaders. We believe in social justice, equity, and basic human rights, and are committed to promoting diversity.

ProMED-mail

The Program for Monitoring Emerging Diseases (ProMED) is one of the largest publicly available emerging disease and outbreak alert systems in the world. ProMED follows the One Health model of covering emerging diseases and toxin exposures in plant, wildlife, and humans. One of the early innovators in using informal information sources to identify unusual health events around the world, ProMED emphasizes transparency, is open to all sources, free of political constraints, and available to anyone free of charge. As of 2016, ProMED has more than 75,000 subscribers in over 185 countries. With an average of 13 posts-per-day, ProMED provides users with up-to-date information concerning infectious disease outbreaks on a global scale. ProMED is a program of the International Society for Infectious Diseases.

Epidemico

Epidemico is a health data collection and analytics company, combining expertise in emerging technology and public health to provide real-time insights on various facets of population health. Our web and mobile platforms serve as trusted resources for the public, government officials, regulatory agencies, life sciences, hospitality and financial companies.

 

Our work has been nationally recognized by the Smithsonian and the Library of Congress, as well as The New York Times, The Wall Street Journal, NBC, and CNN. Epidemico is a spinoff from Boston Children's Hospital, Harvard Medical School, and MIT; our team is composed of public health informaticians, epidemiologists, clinicians, computer scientists, and software developers.

SUPPORTERS

mindberry

"mindberry" helps businesses around the globe to be more user-friendly and more profitable. They are experts in understanding and influencing online shoppers and offer the following services:

  • User Research: They conduct user research, evaluate user interfaces, test usability, benchmark competing websites, and analyze user behavior.

  • Sales & Conversion Optimization: They help their clients convert more of their site visitors to customers. 

Life Science Austria Vienna

Life Science Austria Vienna - LISAvienna - is the joint life science platform operated by Austria wirtschaftsservice and the Vienna Business Agency. On behalf of the Austrian Federal Ministry of Science, Research and Economics and the city of Vienna, LISAvienna contributes to the advancement of life sciences in Vienna.

As head of the focus program Life Science Austria (LISA) at austria wirtschaftsservice (aws), the Austrian funding bank, Johannes Sarx is responsible for the strategic planning and implementation of measures to strengthen Austria as a life science location. In his function as Investment Manager, he supports the development and financing of innovative Austrian life science start-ups. Since 2012, he has acted as Managing Director of LISAvienna, together with Peter Halwachs, Vienna Business Agency. Previously, Johannes Sarx worked as a Senior Consultant at the strategy consultancy company Alcimed, which specializes in life sciences and pharmaceuticals. After completing his studies in molecular biotechnology at the Dresden University of Technology, Johannes Sarx graduated from the MBA program at the University of Arizona, specializing in finance and entrepreneurship.

Johannes Sarx
MIT Hacking Medicine

MIT Hacking Medicine, based out of Massachusetts Institute of Technology (MIT) in Cambridge, Massachusetts, is a student and community led group with a mission to energize the healthcare ecosystem by teaching healthcare entrepreneurship and digital strategies to scale medicine and solve meaningful healthcare problems globally. Hacking has always been a core part of the MIT culture. Hacking Medicine disrupts the silos that are prevalent in healthcare and public health by bringing together passionate individuals with technology and healthcare backgrounds to solve relevant problems. Teams coming out of our events have had successes joining prestigious accelerators (such as TechStars, Y-Combinator, Healthbox, and Rock Health), raising significant investment funding, and partnering with healthcare institutions or companies towards implementing their hack ideas. To date, we are proud to say that we have helped inspire the formation of nearly 20 active companies that have raised over $90M in financing. 

The International Society for Infectious Diseases

The International Society for Infectious Diseases (ISID) – with more than 70,000 members from 201 countries - is a non-profit, apolitical organization committed to the control of emerging and re-emerging infectious diseases around the globe. The Society has a particular focus on resource-limited countries that disproportionally bear the burden of infectious diseases. ISID’s many programs recognize that infectious diseases cross all national and geographic boundaries and that effective control and prevention solutions require an international exchange of information. Programs of the Society include the International Congress on Infectious Diseases (ICID), ProMED-mail, the International Journal of Infectious Diseases, and grant opportunities for young investigators in the public health community. Membership with the society is free of charge. 

Christopher Lee is currently a PhD Candidate in the joint Harvard-MIT Division of Health Sciences and Technology working in the Koch Institute for Integrative Cancer Research developing new drug delivery techniques and therapeutics for urological diseases. 

 

Chris is former Co-Director (2015-2016) for MIT Hacking Medicine and founder of Recon Therapeutics, a medical device start-up focused on providing an improved platform to help patients mix, dose, and inject therapeutics that are delivered in a powered form. Chris also recently cofounded a telemedicine company, InfiniteMD, which connects patients around the world to top specialists for online medical second opinions. Some of Chris’s recent awards include selection as a World Economic Forum Global Shaper, 2015 Forbes 30 Under 30 Honoree in Healthcare, and an Inc.com top 50 young entrepreneur under 25.

Christopher Lee

Lin Yang is an assistant professor of Epidemiology at the Medical University of Vienna, serving since 2016. Prior to Vienna, she received her PhD degree in Epidemiology with a focus on physical activity and public health, and natural experiments in active transport research from the University of Cambridge (UK) in 2012. Between 2013 and 2015, she undertook postdoctoral training at Washington University School of Medicine (St. Louis, USA) in the Transdisciplinary Research on Energetics and Cancer (TREC) center, investigating the role of physical activity and obesity in cancer survivorship. Her primary research interests relate to innovative interventions targeting obesity, nutrition and physical activity for cancer prevention and survivorship care.

Lin Yang​

Katerina is a PhD student in the Harvard-MIT Health Sciences and Technology (HST) Program, a member of the Cima Lab at the MIT Koch Institute, and a Tata Fellow. She designs implants for drug delivery to the abdomen, with a focus on making intraperitoneal cancer therapy more accessible and safe for patients, easier to administer for healthcare providers, and more cost-effective for cancer care in limited-resource settings.

 

Katerina grew up in Athens, Greece and came to the US in 2007 to attend Harvard College. Her goal is to be an innovator in affordable medical technologies. At MIT, alongside her research Katerina is a co-founder of the Cost-effective Healthcare Initiative, teaches a course on the design and commercialization of low-cost prosthetic technologies, and helps drive sustainable medical innovation with MIT Hacking Medicine and the MGH Consortium for Affordable Medical Technologies.

Katerina Mantzavinou

Joao is a Ph.D. candidate doing his research at Harvard Medical School, Brigham and Women's Hospital, and MIT. There he develops new platforms for drug discovery and technological tools with biomedical applications. Joao is passionate about translational research and entrepreneurship as a way of promoting innovation and leading to breakthroughs in healthcare worldwide.

Joao Ribas

Winter is an MIT EE/CS student pursuing robotics and applied machine learning. His research work at MIT spans a wide range of topics including the development of high-speed autonomous racing vehicles, NLP medical research tools, and myoelectric prosthetic arms, the latter of which have been showcased in the MIT museum.

Winter Joseph Guerra

John W. Ramatowski is the Assistant Program Director at the International Society for Infectious Diseases. He graduated from Tufts University with degrees in Biology and Public Health. At Tufts, he served as the founder and director of Tufts One Health – a multi-institution strategy promoting the One Health concept and cross-university enrollment opportunities for all students. As a developer and lecturer of an undergraduate One Health course, a One Health major, and associated concentration, he combines his knowledge as an aspiring public health professional with his first responder clinical skills as he pursues an MD degree. His research interests focus on the connection between mass migration events and their impact on the spread of infectious disease outbreaks in novel populations. 

John W. Ramatowski